The Infection Surveillance Solutions Market Size is valued at USD 544.93 Mn in 2022 and is predicted to reach USD 1581.37 Mn by the year 2031 at a 12.7 % CAGR during the forecast period for 2023-2031.
The term "infection surveillance solutions" refers to systems continuously tracking and managing information on healthcare-associated infections (HAIs) for public health evaluation. The effective implementation of preventative interventions depends on the early recognition of sickness. The two main factors pushing the growth of the infection surveillance solutions systems market are the rise in microbial resistance to antibiotics and the increased usage of automation in healthcare settings.
The rise in hospital-associated illnesses, such as urinary tract infections, surgical site infections, and poor sanitation, drives the market for infection surveillance solutions. Furthermore, The rise in the practice of self-medication, the expansion of IT systems' analytical processing capabilities, and non-adherence to prescribed medication all impact the market for infection surveillance systems.
Additionally, the market for infection surveillance solutions is positively impacted by government initiatives in the form of policies, an increase in healthcare spending, an increase in the number of surgeries, and research and development activities. On the other hand, the market expansion for infection surveillance solutions is anticipated to be hampered by the high cost of the software, medical professionals' resistance to utilizing cutting-edge healthcare products, and a shortage of operating skilled it professionals.
The infection surveillance solutions market is segmented on the basis of products & services, and End-User. Based on the product & services, the segmentation is as software which includes on-premise and web-based software and up to 50 hp, which consists of product support & maintenance services, implementation services and training & consulting services). Based on End-User, the market segments are hospitals (large, medium-sized hospitals, and small hospitals), long-term care facilities (nursing homes, skilled nursing facilities and assisted-living facilities), and other end users.
The software category will hold a major share of the global market in 2022. Technology development has contributed to this rise by enabling efficient patient data management, research, and comprehension. Elation Health is a cloud-based, clinically focused solution for doctors looking for an ONC-ATCB-approved electronic medical record (EMR), including patient appointments, a patient portal, e-prescribing, and e-faxing. Electronic medical records are progressively being utilized as part of the software segment because of the benefits the cloud provides, such as cheaper maintenance costs, enhanced collaboration, good backup and restore data capabilities, and more convenience.
The segment, hospital, is estimated to grow rapidly in the global infection surveillance solutions market. Hospitals have significant purchasing power, and their involvement in the system-building process has contributed to their dominance. In addition, hospitals have stronger HAI management skills and can monitor patients within the allotted period. Over 45% of hospitals are thought to use software and surveillance systems for speedier illness analysis. They installed automated technologies to examine historical infection patterns through simulation, aiding in the containment of healthcare-acquired illnesses in healthcare institutions.
The North American infection surveillance solutions market is expected to record the major market share in revenue. The stricter regulations and the substantial number of companies providing infection surveillance solutions in North America are driving factors in the market for these products. The prevalence of HAIs in the U.S. and Canada is on the rise, and this, combined with strong government measures, is anticipated to fuel regional market expansion.
To tackle germs that are resistant to antibiotics, such as the prevalence of Clostridium difficile, Carbapenem-resistant Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus, the National Action Plan (NAP), a five-year action plan, was introduced. In addition, Asia-Pacific is expected to grow at the quickest rate. The primary forces in the area are the growing public awareness of health issues, rising healthcare spending, increased healthcare facilities, and quick advancements in health insurance.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 544.93 Mn |
|
Revenue Forecast In 2031 |
USD 1581.37 Mn |
|
Growth Rate CAGR |
CAGR of 12.7 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product & Services, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US). |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Infection Surveillance Solutions Market Snapshot
Chapter 4. Global Infection Surveillance Solutions Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product & Services Estimates & Trend Analysis
5.1. By Product & Services & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Product & Services:
5.2.1. Software
5.2.1.1. On-premise Software
5.2.1.2. Web-based Software
5.2.2. Services
5.2.2.1. Product Support & Maintenance Services
5.2.2.2. Implementation Services
5.2.2.3. Training & Consulting services
Chapter 6. Market Segmentation 2: By End User Estimates & Trend Analysis
6.1. By Product & Services & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End User:
6.2.1. Hospitals
6.2.1.1. Large Hospitals
6.2.1.2. Medium Sized Hospitals
6.2.1.3. Small Hospitals
6.2.2. Long-term Care Facilities
6.2.2.1. Nursing Homes
6.2.2.2. Skilled Nursing Facilities
6.2.2.3. Assisted- Living Facilities
6.2.3. Other End Users
Chapter 7. Infection Surveillance Solutions Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By Product & Services, 2023-2031
7.1.2. North America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.1.3. North America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.1.3.1. U.S.
7.1.4. Canada
7.2. Europe
7.2.1. Europe Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, 2023-2031
7.2.2. Europe Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.2.3. Europe Infection Surveillance Solutions Market revenue (US$ Million) by country, 2023-2031
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, 2023-2031
7.3.2. Asia Pacific Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.3.3. Asia Pacific Infection Surveillance Solutions Market revenue (US$ Million) by country, 2023-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, 2023-2031
7.4.2. Latin America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.4.3. Latin America Infection Surveillance Solutions Market revenue (US$ Million) By country, (US$ Million) 2023-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, (US$ Million)
7.5.2. Middle East & Africa Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.5.3. Middle East & Africa Infection Surveillance Solutions Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Becton, Dickinson and Company (US)
8.2.2. Premier, Inc. (US)
8.2.3. Wolters Kluwer N.V. (Netherlands)
8.2.4. Cerner Corporation (US)
8.2.5. Baxter International Inc. (US)
8.2.6. GOJO Industries, Inc. (US)
8.2.7. Clinisys (US)
8.2.8. Deb Group Ltd. (UK)
8.2.9. BioVigil Healthcare Systems (US)
8.2.10. RLDatix (UK)
8.2.11. Merative (US)
8.2.12. Vecna Technologies, Inc. (US)
8.2.13. VigiLanz Corporation (US)
8.2.14. Ecolab (US)
8.2.15. Harris Healthcare (US)
8.2.16. PeraHealth (US)
8.2.17. Medexter Healthcare (Austria)
8.2.18. CenTrak, Inc. (US)
8.2.19. BioMerieux SA (France)
8.2.20. CKM Healthcare (Canada)
8.2.21. Asolva Inc. (US)
8.2.22. PointClickCare (Canada)
8.2.23. STANLEY Healthcare (US)
8.2.24. Vitalacy Inc. (US)
Infection Surveillance Solutions Market By Product & Services
Infection Surveillance Solutions Market By End User
Infection Surveillance Solutions Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
